Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
ADPT

Adaptive Biotechnologies Corporation (ADPT)

NASDAQ
$28.44
-$0.04
(-0.14%)
Previous Close: ⁦$28.49⁩
Market Closed

Last updated: ⁦2026-11-19 02:28:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Adaptive Biotechnologies Corporation (ADPT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $28.44, with a market capitalization of $4.51B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $12.00 to $32.21. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$4.51B

$27.79

$29.20

$27.79

$28.49

1.93M

2.19M

--

$32.21

$12.00

--

2026-09-30

Adaptive Biotechnologies Corporation (ADPT) Latest Closing Stock Price

Adaptive Biotechnologies Corporation (ADPT) last closed at $28.44 as of 2026-11-19 00:31:00, down 0.14% ($0.04) from the previous close of $28.49.

During the latest regular trading session, ADPT traded between $27.79 and $29.20, with a volume of 1.93M shares. The closing price was near the middle and near the upper end of its 52-week range.

Adaptive Biotechnologies Corporation (ADPT) 7-Day Stock Price Change

Over the past seven days, Adaptive Biotechnologies Corporation (ADPT) moved from $30.26 to $28.44, representing a decline of 6.01% ($1.82).

The stock traded between $27.29 and $32.21 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 2.27 million shares, down versus the previous seven-day period, indicating lower trading activity.

ADPT 52-Week Price Position

Position in Range: 81.3%

52W Low$12.00
52W High$32.21

ADPT is currently trading at $28.44, placing it 81.3% of the way from its 52-week low of $12.00 to its 52-week high of $32.21. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Adaptive Biotechnologies Corporation (ADPT)?

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Adaptive Biotechnologies Corporation Information

Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
624
Exchange
NASDAQ
Company Website

ADPT News

Latest news related to Adaptive Biotechnologies Corporation and ADPT stock.

  • Benzinga

    Adaptive’s clonoSEQ To Be Featured In About 100 Abstracts, Including 27 Oral Presentations, At ASH 2026 In New Orleans, Highlighting MRD-Guided Care

    Read Full Article
  • Massive

    Here's Why You Should Add AURA Stock to Your Portfolio Now

    Aura Biosciences completed enrollment and dosing in its phase III CoMpass study evaluating bel-sar for early choroidal melanoma treatment. Top-line data is expected in the second half of 2027. If successful, bel-sar could become the first FDA-approved frontline vision-preserving therapy for this indication. The company is also exploring bel-sar for choroidal metastases and ocular surface cancers, with updates expected in Q1 2027. AURA shares have risen 39.6% year-to-date.

    Read Full Article
  • Massive

    Zoetis' Cytopoint Plus Gets USDA License for 75-Day Canine Itch Relief

    Zoetis announced USDA approval for Cytopoint Plus, a monoclonal antibody therapy providing 75 days of relief from allergic itch in dogs. The extended dosing interval is approximately 1.5 times longer than existing mAb options, expanding Zoetis' canine dermatology portfolio alongside Cytopoint, Apoquel, and Apoquel Chewable. Market uptake will depend on pricing, veterinary recommendations, and real-world performance.

    Read Full Article
  • Massive

    BEAM Stock Falls 7% Despite Meeting Primary Endpoints in SCD Study

    Beam Therapeutics reported positive top-line results from its BEACON study for risto-cel, a gene-editing therapy for sickle cell disease, achieving primary efficacy and safety endpoints with patients demonstrating freedom from severe vaso-occlusive crises for at least 12 consecutive months. The company plans to submit a biologics license application to the FDA by end of 2026, potentially marking the first commercial product approval for a base-editing therapy. Despite the encouraging clinical results, BEAM shares declined 7% following the announcement, likely due to concerns over weaker third-quarter results and profit-taking.

    Read Full Article

Ways to Trade ADPT at MEXC

ADPT MEXC RealStocks

Own real ADPT shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Adaptive Biotechnologies Corporation (ADPT) Stock on MEXC

Eligible investors can buy real shares of Adaptive Biotechnologies Corporation (ADPT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for ADPT and Place Your Order
Step 3: Search for ADPT and Place Your Order
Open the RealStocks trading page and search for ADPT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Adaptive Biotechnologies Corporation (ADPT) stock price today?
Adaptive Biotechnologies Corporation (ADPT) is currently trading at $28.44, down 0.14% ($0.04) from the previous close of $28.49. Intraday prices update in real time during regular trading hours.
2.Is ADPT stock going up or down today?
As of 2026-11-19 00:31:00, ADPT is trading at $28.44, down 0.14% ($0.04) from its previous close of $28.49. The stock has traded between $27.79 and $29.20 during today’s regular session. Past price movements do not guarantee future results.
3.What is ADPT pre-market price?
As of 2026-11-19 00:31:00, ADPT is trading at $28.56 in pre-market trading, up 0.26% ($0.07) from the previous close of $28.49. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is ADPT after-hours price?
As of 2026-11-19 00:31:00, ADPT is trading at $29.04 in after-hours trading, up 2.09% ($0.59) from the regular-session close of $28.44. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is ADPT stock trading now?
ADPT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does ADPT sit relative to its 52-week high and low?
Over the past 52 weeks, ADPT has traded between a low of $12.00 and a high of $32.21. At $28.44, the stock is positioned 81.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Adaptive Biotechnologies Corporation in?
Adaptive Biotechnologies Corporation (ADPT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Adaptive Biotechnologies Corporation's market capitalization and where is it listed?
Adaptive Biotechnologies Corporation is listed on the NASDAQ exchange with a market capitalization of $4.51B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is ADPT valued in terms of P/E ratio and EPS?
ADPT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-0.44. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Adaptive Biotechnologies Corporation pay a dividend?
Adaptive Biotechnologies Corporation pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ADPT, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

ADPT Stock Calculator

Estimate the value between ADPT shares and USD.

ADPT Shares to USD

ADPT Shares
ADPT
ADPT
USD
USD
USD

1.00 ADPT shares = 28.44 USD

Calculations are estimates based on the latest available price and are for reference only.